PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsDoxecitine
Doxecitine
Doxecitine is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
5210 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CarcinomaD002277C80.01617
Renal cell carcinomaD002292EFO_0000376112
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Neoplasm metastasisD009362EFO_0009708213
Urinary bladder neoplasmsD001749C67213
Breast neoplasmsD001943EFO_0003869C50112
Non-small-cell lung carcinomaD002289112
Lung neoplasmsD008175C34.9011
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C80537
Pancreatic neoplasmsD010190EFO_0003860C25223
CholangiocarcinomaD018281C22.1123
Hepatocellular carcinomaD006528C22.033
Liver neoplasmsD008113EFO_1001513C22.033
Colorectal neoplasmsD01517922
Bile duct neoplasmsD001650122
Digestive system neoplasmsD004067112
Gastrointestinal stromal tumorsD046152EFO_0000505C49.A112
Gallbladder neoplasmsD005706EFO_0004606C2322
Show 8 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-hodgkin lymphomaD008228C85.911
Follicular lymphomaD008224C8211
Large b-cell lymphoma diffuseD016403C83.311
Triple negative breast neoplasmsD06472611
ThymomaD01394511
Gastrointestinal neoplasmsD005770C26.911
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDoxecitine
INNdoxecitine
Description
Deoxycytidine is a deoxyribonucleoside, a component of deoxyribonucleic acid. It is similar to the ribonucleoside cytidine, but with one hydroxyl group removed from the C2' position.
Classification
Small molecule
Drug classH2-receptor antagonists (cimetidine type)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1
Identifiers
PDB
CAS-ID951-77-9
RxCUI
ChEMBL IDCHEMBL66115
ChEBI ID15698
PubChem CID637
DrugBankDB02594
UNII ID0W860991D6 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
27 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use